Title : Effects of olmesartan medoxomil, an angiotensin II type 1 receptor antagonist, on plasma concentration of B-type natriuretic peptide, in hypertensive patients with type 2 diabetes mellitus: a preliminary, observational, open-label study.

Pub. Date : 2011

PMID : 21184621






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The objective of this study was to determine the effects of olmesartan medoxomil, a novel ARB, on the plasma level of BNP in hypertensive patients with type 2 diabetes. olmesartan natriuretic peptide B Homo sapiens
2 Change in plasma BNP level over the 24-week treatment period in the olmesartan medoxomil group was not correlated with change in SBP or DBP. olmesartan natriuretic peptide B Homo sapiens
3 CONCLUSION: The current preliminary study showed that olmesartan medoxomil treatment might decrease plasma BNP levels, independent of its BP-lowering effect, in hypertensive patients with type 2 diabetes. olmesartan natriuretic peptide B Homo sapiens